Clean Science And Technology: Business Overview & Financial Analysis
Clean Science And Technology is a global specialty chemicals manufacturing enterprise headquartered in Pune, Maharashtra. Promoted by Ashok Ramnarayan Boob and family, the company manufactures eco-friendly, green chemistry-based performance chemicals, pharmaceutical intermediates, FMCG chemicals, and Hindered Amine Light Stabilizers (HALS) using in-house catalytic synthesis processes. Operating four integrated manufacturing facilities at Kurkumbh MIDC (Maharashtra) alongside an active R&D network, Clean Science And Technology supplies global blue-chip corporations across 35+ countries.
Segment Revenue Mix of Clean Science And Technology (Q1 FY2027)
Clean Science And Technology structures its operating revenues across performance chemicals, pharmaceutical intermediates, FMCG chemicals, and advanced light stabilizers.
- Performance Chemicals Segment Share – 81.0% of Total Operating Revenue
- Pharma & Agro Intermediates Share – 12.0% of Total Operating Revenue
- FMCG & Other Specialty Chemicals Share – 7.0% of Total Operating Revenue
- Total Consolidated Revenue from Operations (Q1 FY2027) – Rs 268.43 crore (+10.5% YoY)
Performance chemicals constitute over eight-tenths of total turnover, driven by the commercial ramp-up of Hindered Amine Light Stabilizers (HALS). Pharma intermediates and FMCG chemicals provide product diversification across global consumer and agricultural markets.
Geographic Revenue Breakdown of Clean Science And Technology (Q1 FY2027)
Clean Science And Technology balances direct domestic dispatches across India with exports across North America, Europe, and Asia-Pacific.
- International Exports Channel Share – 61.0% of Total Operating Revenue
- Domestic Indian Market Sales Share – 39.0% of Total Operating Revenue
- Overseas Distribution Reach – Direct product dispatches across 35+ countries globally
- Strategic Overseas Subsidiaries – Incorporated a wholly owned European sales subsidiary
Overseas export dispatches account for six-tenths of total turnover, supported by global distribution channels. Incorporating a European sales subsidiary strengthens regional customer proximity and international business expansion.
Product Portfolio & Market Leadership of Clean Science And Technology (FY2026)
Clean Science And Technology holds dominant market shares across core specialty chemical compounds globally.
- Monomethyl Ether of Hydroquinone (MEHQ) Global Position – #1 Global Producer (>50% World Market Share)
- Butylated Hydroxy Anisole (BHA) Global Position – #1 Global Producer
- 4-Methoxy Acetophenone (4-MAP) Global Position – #1 Global Producer
- Guaiacol & Anisole Global Positions – #1 Global Producer
- Top 4 Legacy Products Revenue Concentration – ~60.0% of Total Sales (De-risked from 85.0% in FY2023)
Clean Science And Technology maintains world leadership in MEHQ, BHA, 4-MAP, Guaiacol, and Anisole. Commercializing new HALS series products has de-risked product concentration, reducing top-4 legacy product dependency to 60%.
HALS Capacity & Subsidiary Scaling via Clean Fino Chem of Clean Science And Technology (Q1 FY2027)
Clean Science And Technology scales its polymer additive portfolio through its wholly owned subsidiary entity, Clean Fino Chem.
- Wholly Owned Subsidiary Entity – Clean Fino Chem (100% Subsidiary)
- HALS Series Sales Contribution – 22.0% of Total Consolidated Sales
- Unit 4 Greenfield Facility Capex Outlay – Rs 500.00 crore deployed
- Targeted Global Market Opportunity – $1.0 Billion HALS Global Market
- Commercial Revenue Target Realisation – Projected ~Rs 700.00 crore at full capacity utilisation
Clean Fino Chem operates as the primary growth engine for Hindered Amine Light Stabilizers (HALS 701, 770, 622, 944). HALS series contribution expanded to 22% of total sales, capturing market share in global polymer additive markets.
Manufacturing Facilities & Infrastructure Scale of Clean Science And Technology (FY2026)
Clean Science And Technology manages integrated manufacturing plants equipped with vapor-phase catalytic reactors and automated processing lines.
- Total Operational Manufacturing Units – 4 integrated facilities in Kurkumbh MIDC (Pune, Maharashtra)
- Total Installed Manufacturing Capacity Base – 44,000+ Metric Tonnes Per Annum (MTPA)
- Dedicated In-House R&D Facilities Base – 4 R&D units with 65+ research scientists
- Total Operating Employee Base – 1,600+ personnel across plants and laboratories
Operating four integrated manufacturing units at Kurkumbh MIDC supports catalytic synthesis of specialty performance chemicals. In-house R&D centers equipped with 65+ scientists develop vapor-phase catalytic processes that eliminate toxic effluent discharges.
Latest Quarterly Financial Performance of Clean Science And Technology (Q1 FY2027)
Clean Science And Technology recorded top-line revenue expansion and operating profit growth during the first quarter of FY2027.
- Consolidated Revenue from Operations – Rs 268.43 crore (+10.5% YoY)
- Total Income from Operations – Rs 290.65 crore (+13.4% YoY)
- Consolidated Operating EBITDA – Rs 96.00 crore (+8.5% YoY)
- Consolidated Operating EBITDA Margin – 35.76%
- Consolidated Net Profit After Tax (PAT) – Rs 73.35 crore (+4.7% YoY)
- Standalone Operating EBITDA Margin – 42.70%
First-quarter consolidated operating revenue expanded 10.5% year-on-year to Rs 268.43 crore, driven by Clean Fino Chem HALS dispatches. Standalone operating EBITDA margins held firm at 42.70%, while consolidated Net Profit After Tax reached Rs 73.35 crore.
Consolidated Annual Financial Performance of Clean Science And Technology (FY2026)
Clean Science And Technology delivered full-year turnover realisations and operating earnings stability for full financial year FY2026.
- Consolidated Revenue from Operations – Rs 885.20 crore (+11.2% YoY)
- Standalone Revenue from Operations – Rs 815.34 crore
- Consolidated Operating EBITDA – Rs 352.87 crore
- Standalone Operating EBITDA Margin – 43.28%
- Consolidated Net Profit After Tax (PAT) – Rs 251.20 crore
- Return on Equity (ROE) – 16.20%
- Return on Capital Employed (ROCE) – 19.52%
Full-year consolidated operating turnover crossed Rs 885 crore in FY2026, as consolidated Net Profit After Tax reached Rs 251.20 crore. Performance was supported by high capacity utilisation in core performance chemicals and green chemistry cost advantages.
Balance Sheet Structure & Capital Health Ratios of Clean Science And Technology (Q1 FY2027)
Clean Science And Technology operates a zero-debt financial structure backed by high operational cash flow conversion and liquid treasury reserves.
- Financial Debt to Equity Ratio – Zero Debt (0.00x)
- Total Cash, Bank Balances & Liquid Investments – Rs 280.00 crore
- Total Consolidated Net Worth Base – Rs 1,645.65 crore
- Dividend Payout Ratio – 21.5% (Final Dividend of Rs 4.00 per share for FY2026)
- Promoter Group Shareholding Share – 51.29%
The enterprise maintains a zero-debt balance sheet supported by Rs 1,645.65 crore in consolidated net worth and Rs 280.00 crore in liquid surplus reserves. High operational cash flows cover ongoing expansion projects without debt reliance.
Capital Expenditure & Expansion Roadmap of Clean Science And Technology (FY2027–FY2028)
Clean Science And Technology executes capital allocation outlays to establish new chemical production blocks, upgrade R&D labs, and scale Clean Fino Chem.
- Quarterly Capex Deployed (Q1 FY2027) – ~Rs 100.00 crore (Invested in Clean Fino Chem)
- Performance Chemical 2 Launch Timeline – Commercial launch targeted by Q3 FY2027
- Additional Capital Infusion Approval – Rs 200.00 crore board approval for Clean Fino Chem
- Strategic Technology Partnership – Signed agreement with Swiss technology partner for advanced HALS chemistry
- Funding Strategy – 100% funded through internal operational cash accruals and liquid surplus reserves
Quarterly capex of Rs 100.00 crore was deployed during Q1 FY2027 to scale Clean Fino Chem manufacturing facilities. Strategic technology collaboration with a Swiss partner enables access to advanced chemistry suites for next-generation HALS series.
Strategic Outlook & Management Commentary of Clean Science And Technology (Q1 FY2027 Concall)
Management guidance outlines strategic priorities centered on HALS volume scaling, Performance Chemical 2 commercialization, and European distribution expansion.
- Management targets accelerating top-line revenue growth driven by HALS ramp-up and new Performance Chemical 2 launches.
- Standalone operating EBITDA margins are guided to sustain above the 40.0%–42.0% corridor through catalytic process efficiency.
- HALS series revenue contribution is projected to scale toward Rs 700.00 crore over the next 2 to 3 years.
- European sales operations will be scaled through the newly incorporated wholly owned European subsidiary.
- Capital allocation strategy will prioritize maintaining a debt-free balance sheet while funding brownfield capex through internal accruals.
Management anticipates expanding market share in global polymer additives to support HALS volume dispatches. Operational focus centers on commercializing Performance Chemical 2 by Q3 FY2027, scaling European distribution, and preserving balance sheet health.
Sources & References
- Clean Science And Technology Q1 FY2027 Earnings Disclosures & Slides (August 2026)
- Clean Science And Technology Q1 FY2027 Financial Results & BSE Filings (August 2026)
- Clean Science And Technology Audited Financial Results & Dividend Disclosures FY2026 (May 2026)
- BSE Limited & National Stock Exchange of India (NSE) Corporate Filings for Clean Science And Technology
- Ticker Finology Clean Science And Technology Page
Disclaimer
The information presented above on Clean Science And Technology has been compiled from the company's Annual Reports, Investor Presentations, Earnings Call (Concall) Transcripts, official regulatory filings and the financial data available on Finology Ticker. Certain figures, classifications or comparisons may vary due to differences in accounting policies, reporting methodologies or subsequent restatements by the company. This content is intended solely for informational purposes and should not be considered as investment advice. Investors are advised to refer to the latest company filings and the updated financial data, ratios and disclosures available on this Finology Ticker Clean Science And Technology page before making any investment decision. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.